Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessReview

Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities

Cornel Pater email

Cornel Pater, Hannover, Germany

author email corresponding author email

Current Controlled Trials in Cardiovascular Medicine 2005, 6:1doi:10.1186/1468-6708-6-1

Published: 3 February 2005

Additional files

Additional File 1:

Frequency distribution of TU morphology changes across two groups.

Format: DOC Size: 29KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 2:

TU morphology changes in individual subjects.

Format: DOC Size: 36KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 3:

Frequency distribution of TU morphology changes across two groups.

Format: DOC Size: 27KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 4:

Frequency distribution of the PR/QRS/QTc(B/F/L) data matching PK sampling (for individuals and/or groups).

Format: DOC Size: 38KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 5:

Summary of PR/QRS/QTc(B/F/L) data (for individuals and/or groups).

Format: DOC Size: 25KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 6:

Normal ranges for the PR/QRS/QTc(B/F/L) data and for the QTc(B/F/L) relative changes to baseline.

Format: DOC Size: 27KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 7:

Frequency distribution of the baseline and on-treatment values pertaining the PR, QRS, QT, QTcB, QTcF and QTcL parameters as well as the D1 difference.

Format: DOC Size: 33KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 8:

Summary of outcome differences between the two groups regarding key ECG parameters.

Format: DOC Size: 30KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 9:

Alert criteria based on ECG findings (measurements) and rational for subject withdrawal from study.

Format: DOC Size: 25KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 10:

Characteristics of the cross-over and parallel study designs.

Format: DOC Size: 29KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 11:

Disease associated with prolonged QT/QTc interval.

Format: DOC Size: 24KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional File 12:

Abbreviations (Not mentioned in the text!)

Format: DOC Size: KB Download file

This file can be viewed with: Microsoft Word Viewer


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com >   Terms and conditions